Brief: JHBP CY Notified By NMPA That New Product Application Approval Of Geptanolimab Was Not Granted
12/06/2023 01:58
June 12 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* NOTIFIED BY NMPA THAT NEW PRODUCT APPLICATION APPROVAL OF
GEPTANOLIMAB (GB226) WAS NOT GRANTED
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman